Research analysts at Deutsche Bank began coverage on shares of Clorox (NYSE:CLX) in a research report issued to clients and investors on Wednesday. The firm set a “hold” rating and a $142.00 price target on the stock. Deutsche Bank’s target price indicates a potential downside of 2.91% from the company’s current price.

Several other research firms also recently commented on CLX. BMO Capital Markets reissued an “outperform” rating on shares of Clorox in a report on Tuesday, September 12th. Consumer Edge raised Clorox from a “neutral” rating to an “outperform” rating in a report on Friday, November 10th. Zacks Investment Research downgraded Clorox from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. Royal Bank of Canada reaffirmed a “hold” rating and set a $115.00 price target on shares of Clorox in a report on Sunday, October 8th. Finally, Jefferies Group reaffirmed a “hold” rating and set a $132.00 price target (down previously from $137.00) on shares of Clorox in a report on Friday, October 6th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $129.05.

Shares of Clorox (NYSE CLX) opened at $146.26 on Wednesday. The company has a market capitalization of $18,900.00, a P/E ratio of 26.15, a PEG ratio of 3.95 and a beta of 0.43. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02. Clorox has a twelve month low of $115.00 and a twelve month high of $147.38.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.41 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.48 billion. Clorox had a return on equity of 161.59% and a net margin of 11.84%. The firm’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.36 EPS. analysts forecast that Clorox will post 5.6 earnings per share for the current year.

In other Clorox news, SVP Matthew T. Laszlo sold 20,051 shares of the stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the transaction, the senior vice president now owns 10,896 shares in the company, valued at approximately $1,421,492.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the transaction, the senior vice president now owns 34,867 shares in the company, valued at approximately $4,742,260.67. The disclosure for this sale can be found here. 1.00% of the stock is owned by company insiders.

A number of hedge funds have recently bought and sold shares of CLX. Valley National Advisers Inc. increased its position in Clorox by 0.6% during the 2nd quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. increased its position in Clorox by 3.9% during the 2nd quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock worth $125,000 after buying an additional 35 shares during the period. Sun Life Financial INC increased its position in Clorox by 10,344.4% during the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after buying an additional 931 shares during the period. Acrospire Investment Management LLC bought a new position in Clorox during the 2nd quarter worth $133,000. Finally, Welch Group LLC increased its position in Clorox by 16.2% during the 2nd quarter. Welch Group LLC now owns 1,228 shares of the company’s stock worth $164,000 after buying an additional 171 shares during the period. Hedge funds and other institutional investors own 73.42% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.watchlistnews.com/deutsche-bank-initiates-coverage-on-clorox-clx/1764904.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.